Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bertucci

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Radiation Research|March 5, 2015
Effect of dose rate on residual γ-H2AX levels and frequency of micronuclei in X-irradiated mouse lymphocytesH C Turner, I Shuryak, M Taveras, et al.
ACS Infectious Diseases|November 20, 2025
The Quorum Sensing-Controlled Competence Regulon Drives H<sub>2</sub>O<sub>2</sub> Production in <i>Streptococcus gordonii</i>Alec A Brennan, Clay P Renshaw, Steven C Tata, et al.
Radiation Protection Dosimetry|July 15, 2016
THE DECADE OF THE RABiT (2005-15)G Garty, H C Turner, A Salerno, et al.
Oncogene|January 7, 2023
Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access programD Bello Roufai, A Gonçalves, T De La Motte Rouge, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Radiation Research|March 5, 2015
Effect of dose rate on residual γ-H2AX levels and frequency of micronuclei in X-irradiated mouse lymphocytesH C Turner, I Shuryak, M Taveras, et al.
ACS Infectious Diseases|November 20, 2025
The Quorum Sensing-Controlled Competence Regulon Drives H<sub>2</sub>O<sub>2</sub> Production in <i>Streptococcus gordonii</i>Alec A Brennan, Clay P Renshaw, Steven C Tata, et al.
Radiation Protection Dosimetry|July 15, 2016
THE DECADE OF THE RABiT (2005-15)G Garty, H C Turner, A Salerno, et al.
Oncogene|January 7, 2023
Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access programD Bello Roufai, A Gonçalves, T De La Motte Rouge, et al.
Pageof 3